摘要
评价131I治疗甲亢合并周期性麻痹(TPP)的疗效,对8例TPP患者用131I治疗,测定治疗前后血清指标。结果表明:血清钾降低,TT3、TT4、FT3、FT4均升高,131I治疗见效快,疗程短,治愈率高,治疗后6个月治愈率75%(6/8),12个月后治愈率100%(8/8),是TPP治疗的首选。
To evaluate therapeutic effect of 131I in thyrotoxic periodic paralysis （TPP） ,the serum TT3, TT4,FT3 and FT4 in 8 TPP Patients before and after treatment with 131I were detected. The results showed that the serum potassium was decreased and serum TT3 ,TT4 ,FT3 and FT4 in those patients were increased. The cure rates in 8 TPP were 75% and 100% after 6 and 12 months treatment with 131I respectively. 131I treatment was a good ther- apeutic effect with short course and high cure rate. 131I is the first choice for the treatment of patients with TPP.
出处
《标记免疫分析与临床》
CAS
2009年第5期289-290,共2页
Labeled Immunoassays and Clinical Medicine
